Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
FCNCA Stock Summary
Top 10 Correlated ETFs
FCNCA
In the News

First Citizens Approaches Buy Point Near Record Highs; SVB Boost Fuels 91% Rally In 2023
IBD Stock Of The Day: First Citizens BancShares is actionable near record highs as its Silicon Valley Bank purchase fuels a major rally.

Banking Consolidation: 3 Stocks to Buy Following Key Acquisitions
Unlike most of the industry, 3 banking juggernauts grew stronger during the recent banking crisis. Stock Strategist Andrew Rocco unveils the 3 strongest banks that benefit from acquisitions.

New Strong Buy Stocks for November 7th
GWRE, REZI, NECB, MSA and FCNCA have been added to the Zacks Rank #1 (Strong Buy) List on November 7, 2023.

Looking for a Growth Stock? 3 Reasons Why First Citizens (FCNCA) is a Solid Choice
First Citizens (FCNCA) possesses solid growth attributes, which could help it handily outperform the market.

First Citizens BancShares, Inc. (FCNCA) Q3 2023 Earnings Call Transcript
First Citizens BancShares, Inc. (NASDAQ:FCNCA ) Q3 2023 Results Conference Call October 26, 2023 9:00 AM ET Company Participants Deanna Hart - Senior Vice President of Investor Relations Frank Holding - Chairman and Chief Executive Officer Craig Nix - Chief Financial Officer Andy Giangrave - EVP, Chief Credit Officer of the Commercial Bank Randy Martin - SVP, Branch Development and Project Management Tom Eklund - Treasurer Conference Call Participants Stephen Scouten - Piper Sandler Brady Gailey - KBW Steven Alexopoulos - JP Morgan Christopher Marinac - I2BBA Brian Foran - Autonomous Brody Preston - UBS Operator Ladies and gentlemen, thank you for standing by. And welcome to the First Citizens Bancshares Third Quarter 2023 Earnings Conference Call.

First Citizens BancShares (FCNCA) Surpasses Q3 Earnings and Revenue Estimates
First Citizens BancShares (FCNCA) came out with quarterly earnings of $55.92 per share, beating the Zacks Consensus Estimate of $48.35 per share. This compares to earnings of $20.77 per share a year ago.

These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

3 Reasons Why Growth Investors Shouldn't Overlook First Citizens (FCNCA)
First Citizens (FCNCA) possesses solid growth attributes, which could help it handily outperform the market.

First Citizens BancShares (FCNCA) Earnings Expected to Grow: Should You Buy?
First Citizens (FCNCA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Green Flags? 3 Stocks That Are Seeing Heavy Insider Buying Right Now.
There's an old saying on Wall Street that there are many reasons to sell a stock, but only one reason to buy: You think the price will go up. That saying is especially true when it comes to executives or board members buying up the stock of a company they manage or oversee.
FCNCA Financial details
FCNCA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 134.78 | 155.03 | 185.44 | 187.3 | 462.59 | |
Net income per share | 33.53 | 41.05 | 48.9 | 55.77 | 111.85 | |
Operating cash flow per share | 64.15 | 48.52 | 33.81 | -28.91 | 284.32 | |
Free cash flow per share | 52.38 | 37.65 | 20.55 | -39.85 | 189.99 | |
Cash per share | 94.22 | 133.25 | 468.29 | 1.9K | 1.48K | |
Book value per share | 292.25 | 320.51 | 420.54 | 482.58 | 984.27 | |
Tangible book value per share | 266.39 | 3.46K | 4.8K | 5.78K | 932.22 | |
Share holders equity per share | 292.25 | 320.51 | 420.54 | 482.58 | 984.27 | |
Interest debt per share | 32.26 | 87.65 | 133.64 | 127.85 | 680.09 | |
Market cap | 4.5B | 5.93B | 5.78B | 8.15B | 7.44B | |
Enterprise value | 4.52B | 6.44B | 6.66B | 9B | 8.11B | |
P/E ratio | 11.24 | 12.96 | 11.74 | 14.88 | 6.78 | |
Price to sales ratio | 2.8 | 3.43 | 3.1 | 4.43 | 1.64 | |
POCF ratio | 5.88 | 10.97 | 16.99 | -28.71 | 2.67 | |
PFCF ratio | 7.2 | 14.13 | 27.95 | -20.83 | 3.99 | |
P/B Ratio | 1.29 | 1.66 | 1.37 | 1.72 | 0.77 | |
PTB ratio | 1.29 | 1.66 | 1.37 | 1.72 | 0.77 | |
EV to sales | 2.81 | 3.73 | 3.57 | 4.9 | 1.79 | |
Enterprise value over EBITDA | 6.84 | 8.94 | 8.77 | 10.8 | 2.45 | |
EV to operating cash flow | 5.91 | 11.91 | 19.59 | -31.72 | 2.91 | |
EV to free cash flow | 7.23 | 15.34 | 32.24 | -23.02 | 4.35 | |
Earnings yield | 0.09 | 0.08 | 0.09 | 0.07 | 0.15 | |
Free cash flow yield | 0.14 | 0.07 | 0.04 | -0.05 | 0.25 | |
Debt to equity | 0.1 | 0.25 | 0.3 | 0.25 | 0.64 | |
Debt to assets | 0.01 | 0.02 | 0.02 | 0.02 | 0.06 | |
Net debt to EBITDA | 0.03 | 0.7 | 1.17 | 1.03 | 0.2 | |
Current ratio | 926.39 | 0 | 0 | 0 | 0.15 | |
Interest coverage | 14.66 | 6.39 | 6.45 | 11.56 | 5.94 | |
Income quality | 1.91 | 1.18 | 0.69 | -0.52 | 2.54 | |
Dividend Yield | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.04 | 0.04 | 0.06 | 0.08 | 0.08 | |
Sales general and administrative to revenue | 0.41 | 0.4 | 0.4 | 0.42 | 0.36 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Capex to operating cash flow | -0.18 | -0.22 | -0.39 | 0.38 | -0.33 | |
Capex to revenue | -0.09 | -0.07 | -0.07 | -0.06 | -0.2 | |
Capex to depreciation | -1.17 | -0.95 | -0.94 | -0.81 | -1.74 | |
Stock based compensation to revenue | 0 | -0.02 | -0.04 | -0.07 | 0 | |
Graham number | 469.56 | 544.11 | 680.19 | 778.18 | 1.57K | |
ROIC | 0.11 | 0.1 | 0.09 | 0.09 | 0.14 | |
Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham Net | -2.57K | 62.2 | 355.04 | 1.79K | -8.45K | |
Working capital | 26.24B | 1.61B | 4.86B | 18.79B | -3.03B | |
Tangible asset value | 3.18B | 38.52B | 48.31B | 56.72B | 9.15B | |
Net current asset value | -5.66B | 723.8M | 3.61B | 17.6B | -99.12B | |
Invested capital | 0.1 | 0.25 | 0.3 | 0.25 | 0.64 | |
Average receivables | 102.58M | 116.53M | 134.42M | 139.97M | 1.5B | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 24.93 | 26.03 | 28.52 | 26.65 | 230.93 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 14.64 | 14.02 | 12.8 | 13.7 | 1.58 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.11 | 0.13 | 0.12 | 0.12 | 0.11 | |
Capex per share | -11.76 | -10.87 | -13.26 | -10.94 | -94.33 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 18.71 | 122.75 | 86.46 | 172.77 | 174.76 | |
Net income per share | 20.05 | 26.18 | 655.21 | 46.94 | 51.76 | |
Operating cash flow per share | 33.6 | 103.91 | -24.92 | 63.05 | 0 | |
Free cash flow per share | 22.98 | 65.1 | -47.77 | 36.76 | 0 | |
Cash per share | 1K | 1.48K | 3.39K | 3.49K | 3.73K | |
Book value per share | 625.83 | 984.27 | 1.32K | 1.36K | 1.4K | |
Tangible book value per share | 594.58 | 932.22 | 1.27K | 1.31K | 1.36K | |
Share holders equity per share | 625.83 | 984.27 | 1.32K | 1.36K | 1.4K | |
Interest debt per share | 501.27 | 656.76 | 3.2K | 2.83K | 2.67K | |
Market cap | 12.53B | 7.44B | 14.14B | 18.65B | 20.05B | |
Enterprise value | 13.64B | 8.11B | 20.11B | 19.94B | 20.27B | |
P/E ratio | 9.94 | 7.24 | 0.37 | 6.84 | 6.67 | |
Price to sales ratio | 42.62 | 6.18 | 11.25 | 7.43 | 7.9 | |
POCF ratio | 23.73 | 7.3 | -39.05 | 20.36 | 0 | |
PFCF ratio | 34.71 | 11.65 | -20.37 | 34.92 | 0 | |
P/B Ratio | 1.27 | 0.77 | 0.74 | 0.94 | 0.98 | |
PTB ratio | 1.27 | 0.77 | 0.74 | 0.94 | 0.98 | |
EV to sales | 46.4 | 6.73 | 16.01 | 7.94 | 7.98 | |
Enterprise value over EBITDA | 21.48 | 4.65 | 86.31 | 23.13 | 18.28 | |
EV to operating cash flow | 25.84 | 7.95 | -55.55 | 21.76 | 0 | |
EV to free cash flow | 37.79 | 12.69 | -28.98 | 37.33 | 0 | |
Earnings yield | 0.03 | 0.03 | 0.67 | 0.04 | 0.04 | |
Free cash flow yield | 0.03 | 0.09 | -0.05 | 0.03 | 0 | |
Debt to equity | 0.79 | 0.64 | 2.4 | 2.03 | 1.85 | |
Debt to assets | 0.07 | 0.06 | 0.21 | 0.19 | 0.18 | |
Net debt to EBITDA | 1.75 | 0.38 | 25.64 | 1.5 | 0.2 | |
Current ratio | 0.18 | 0.15 | 1.67 | 102.16 | 1.91 | |
Interest coverage | 4.57 | 6.77 | 0.39 | 0.9 | 0.89 | |
Income quality | 1.68 | 3.97 | -0.04 | 1.34 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.06 | 0.1 | 0 | 0.04 | 0 | |
Sales general and administrative to revenue | 1.39 | 0.34 | 0.39 | 0.34 | 0.32 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.32 | -0.37 | 0.92 | -0.42 | 0 | |
Capex to revenue | -0.57 | -0.32 | -0.26 | -0.15 | 0 | |
Capex to depreciation | -1.3 | -2.84 | -2.68 | 11.24 | 0 | |
Stock based compensation to revenue | 0.01 | 0 | 0 | 0 | 0 | |
Graham number | 531.32 | 761.45 | 4.42K | 1.2K | 1.28K | |
ROIC | 0.02 | 0.07 | 0 | 0.01 | 0.01 | |
Return on tangible assets | 0 | 0 | 0.04 | 0 | 0 | |
Graham Net | -5.23K | -8.45K | -9.96K | -9.41K | -9.47K | |
Working capital | -2.56B | -3.03B | 674M | 53.31B | 413M | |
Tangible asset value | 9.34B | 9.15B | 18.51B | 19.05B | 19.71B | |
Net current asset value | -98.9B | -99.12B | -193.76B | -135.89B | -192.51B | |
Invested capital | 0.79 | 0.64 | 2.4 | 2.03 | 1.85 | |
Average receivables | 2.18B | 2.53B | 2.52B | 2.67B | 2.65B | |
Average payables | 0 | 0 | 0 | 256M | 256M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 668.57 | 214.58 | 154.99 | 114.13 | 74.72 | |
Days payables outstanding | 0 | 0 | 0 | 44.82 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.13 | 0.42 | 0.58 | 0.79 | 1.2 | |
Payables turnover | 0 | 0 | 0 | 2.01 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.03 | 0.03 | 0.5 | 0.03 | 0.04 | |
Capex per share | -10.63 | -38.81 | -22.85 | -26.29 | 0 |
FCNCA Frequently Asked Questions
What is First Citizens BancShares, Inc. stock symbol ?
First Citizens BancShares, Inc. is a US stock , located in Raleigh of Nc and trading under the symbol FCNCA
Is First Citizens BancShares, Inc. buy or a sell ?
1 stock analysts have 1 predictions with a medium analyst target price of $1700. The lowest prediction is $1700 and the highest is $1700
What is FCNCA stock prediction ?
With a median analyst target price of $1700, 1 stock analysts have made 1 forecasts in last 90 days. $1700 is the lowest and $1700 is the greatest projection.
What is First Citizens BancShares, Inc. stock quote today ?
First Citizens BancShares, Inc. stock price is $1429.735 today.
Is First Citizens BancShares, Inc. stock public?
Yes, First Citizens BancShares, Inc. is a publicly traded company.